Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

On July 6, BioPharma Dive reported that drug developers producing new medicines for the treatment of autoimmune disorders and ...

Looking for the latest stock opportunities in August 2026? We have you covered. Click to read our top stock picks to consider ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotechnology companies are coming out of a dark period for the industry. Why has the tide turned and is now a good time to ...

BioAge Labs, Inc. (NASDAQ:BIOA) is one of the best low-priced pharma stocks on this list. TheFly reported on June 16 that BIOA announced the dosing of the first participant in QUELL-CV, a Phase 2 ...

Pharma Stocks to Buy: Pharma stocks remain in focus as analysts see upside in select large- and mid-cap names. Glenmark tops ...

Shares of Crinetics Pharmaceuticals(NASDAQ: CRNX) jumped 98% this week, according to data from S&P Global Market Intelligence ...

Incyte(NASDAQ: INCY) and TG Therapeutics(NASDAQ: TGTX) are commercial-stage biotech companies that are using blockbuster drugs to fund the growth of their promising pipelines. Incyte is known for its ...